Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

Acquisition

2 May 2006 10:25

Torex Retail PLC02 May 2006 TOREX RETAIL PLC ("Torex Retail" or "the Group") EXPANSION OF PETROLEUM ACTIVITIES WITH ACQUISITION OF LEADING UK SERVICE PROVIDER Torex Retail, an international market leader in the provision of innovative ITsolutions, is pleased to announce the acquisition of TQIPS Limited ("TQIPS"), aleading provider of project management and services to UK petroleum retailers. The initial consideration payable of £7.25 million is to be satisfied by theissue to the vendors of 7.25 million ordinary shares in Torex Retail. Furtherconsideration of up to £3.5 million will be payable to the vendors dependentupon the profitability of TQIPS in the two years ending 31 December 2007. Anyadditional consideration payable will be satisfied through the issue of TorexRetail ordinary shares. Application has been made to the London Stock Market for the 7,250,000 sharesissued on completion to be admitted to trading on AIM. It is expected thatadmission will occur on 5 May 2006. Brendan Kavanagh , Head of Worldwide Petroleum for Torex Retail, commented : "Strategically TQIPS is a very important acquisition and a natural expansion ofour petroleum retail business. TQIPS has an unrivalled reputation for serviceand completes our overall service offering to the Major Oil Companies and majorsupermarket chains. Their blue chip customer list including Tesco, Asda,Morrisons, BP and Texaco further strengthens our base in this market whichalready includes Jet, Esso, Shell, Somerfields, Maxol, Lakeside Group and alarge number of independent dealers." This acquisition positions us extremely well to win significantly more businessin this expanding sector, including our target of achieving major contract winsfor LUCAS Petroleum." Ends. For further information please contact: Torex Retail plc: +44 (0) 870 300 6061 Brendan Kavanagh , Head of Worldwide Petroleum Mark Pearman , Group Finance Director Citigate Dewe Rogerson: +44 (0) 20 7638 9571 Seb Hoyle This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Oct 20167:00 amRNSInterim Results
28th Sep 20167:00 amRNSNotice of Interim Results
15th Sep 20163:07 pmRNSEdison issues outlook on Tissue Regenix
1st Sep 20167:00 amRNSDermaPure® Medicare coverage in further 10 States
3rd Aug 20167:15 amRNSHardman & Co Research Report on: Tissue Regenix
28th Jul 201610:58 amRNSEdison research outlook on Tissue Regenix (TRX)
18th Jul 201611:20 amRNSTR1- NOTIFICATION OF MAJOR INTEREST IN SHARES
11th Jul 20167:00 amRNSOrthopaedics Update
4th Jul 201610:41 amRNSResult of AGM
1st Jul 20167:00 amRNSDermaPure® secures first GPO contract in US
30th Jun 20167:00 amRNSDeferred Annual Bonus Scheme
1st Jun 20167:00 amRNSNew appointment adds clinical expertise to Board
23rd May 20167:00 amRNSPreliminary results for year ended 31 January 2016
20th Apr 20167:00 amRNSNotice of Preliminary Results
14th Apr 20167:00 amRNSChange of Registered Office
24th Mar 20164:40 pmRNSSecond Price Monitoring Extn
24th Mar 20164:35 pmRNSPrice Monitoring Extension
11th Mar 20163:02 pmRNSTR1- NOTIFICATION OF MAJOR INTEREST IN SHARES
9th Mar 20167:00 amRNSFurther Medicare Coverage for DermaPure®
9th Mar 20167:00 amRNS510k market clearance granted for SurgiPureT XD
11th Feb 20167:00 amRNSVP, Orthopaedic, Inc. North America appointed
3rd Feb 20167:00 amRNSDermaPure to be Showcased in Nine Posters at SAWC
26th Jan 201612:21 pmRNSJoint Venture Agreement
25th Jan 20167:00 amRNSHardman & Co Research Report
20th Jan 20167:00 amRNSDermaPure® breaks through $1m sales mark
19th Jan 20167:00 amRNSAppointment of Non-Executive Director
18th Jan 20167:00 amRNSOrthoPureT XM clinical trial enrolment completed
23rd Dec 201512:40 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
4th Dec 20157:00 amRNSOrthoPureT XT implants successfully undertaken
5th Nov 20154:42 pmRNSIssue of equity and total voting rights
26th Oct 20157:00 amRNSIssue of equity and total voting rights
23rd Oct 20157:49 amRNSNon-Executive Director Share Purchase
14th Oct 20154:09 pmRNSEdison initiates coverage of Tissue Regenix
12th Oct 20157:00 amRNSInterim Results
4th Sep 201510:11 amRNSNotice of Interim Results and Capital Markets Day
30th Jul 20157:00 amRNSFurther Medicare Coverage Approval for DermaPure
22nd Jul 20157:00 amRNSAdditional US regional distribution agreement
26th Jun 20157:00 amRNSFurther Medicare Coverage Approval for DermaPure®
12th Jun 201512:43 pmRNSResult of AGM
1st Jun 20159:17 amRNSDermaPure saves 18 year old's leg from frost bite
21st May 20159:51 amRNSHolding(s) in Company
20th May 20157:00 amRNSEmployee SAYE Share Plan
12th May 20157:00 amRNSDeferred Annual Bonus Award
11th May 20157:00 amRNSFinal Results
11th May 20157:00 amRNSFurther Medicare Coverage Approval for DermaPure
5th May 20157:02 amRNSUS regional distribution agreement signed
1st May 20154:01 pmRNSHolding(s) in Company
29th Apr 20157:01 amRNSDermaPure US Clinical data to be presented at SAWC
28th Apr 20157:00 amRNSOrthoPureT XT (Tendon) UK Clinical Trial Approval
9th Mar 20152:05 pmRNSNotice of Preliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.